TETRALOGIC PHARMACEUTICALS Corp — key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2015)

$0

Net Income/Loss (FY2015)

-$49.7M

Total Assets (FY2015)

$64.0M

Total Equity (FY2015)

-$5.9M

Cash Flows from Operating Activities (FY2015)

-$34.9M

Source: TETRALOGIC PHARMACEUTICALS Corp 10-K filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.